Concepedia
Statistics
Publications
7
Citations
328
H-Index
Active since
2016
Affiliations
Eli Lilly (United States)(Current)
University of Indianapolis
Indiana University – Purdue University Indianapolis
Thomas G. Pottanat is an author at Eli Lilly (United States) specializing in medicine, immunology, and pharmacology.
Top concepts
MedicineImmunologyPharmacologyBioanalysisImmunotherapyDrug DiscoveryVascular BiologySignal TransductionAntibody EngineeringMolecular Pharmacology
Publications per year
2016–2021
Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
Yan Chen, Thomas G. Pottanat, Robert W. Siegel et al. · Journal of Lipid Research · 2020 · 141 citations · Full text
ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition
Yan Chen, Thomas G. Pottanat, Yuejun Zhen et al. · Journal of Lipid Research · 2021 · 76 citations · Full text
Immunology, Inflammation, Metabolic Syndrome +21
Affinity capture elution bridging assay: A novel immunoassay format for detection of anti-therapeutic protein antibodies
Yan Chen, Thomas G. Pottanat, Quincy L. Carter et al. · Journal of Immunological Methods · 2016 · 41 citations
Novel Immunoassay Format, Allergy, Bioanalysis +9
Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity
Yan Chen, Thomas G. Pottanat, Robert W. Siegel et al. · Heliyon · 2021 · 23 citations · Full text
LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological Profiles
Yan Jin, Claire Smith, Leijun Hu et al. · Clinical and Translational Science · 2017 · 22 citations · Full text
1–5 of 7